SCHEMBL20766320

SCHEMBL20766320

NS(=O)(=O)c1ccccc1Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGES2 Q9H7Z7 8/20 0.65
▸ CA2 P00918 8/20 0.54
▸ CA1 P00915 7/20 0.51
▸ CA12 O43570 2/20 0.50
▸ CA9 Q16790 2/20 0.50
▸ CA6 P23280 1/20 0.50
▸ CA5A P35218 1/20 0.50
▸ CA7 P43166 1/20 0.50
▸ CA5B Q9Y2D0 1/20 0.50
▸ KIF11 P52732 1/20 0.47
▸ MAPT P10636 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ GFER P55789 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ AR P10275 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766620 0.81 CA2 (0.62) PTGES2CA2CA1CA12CA9
SCHEMBL1921457 0.79 ALDH1A1 (0.55) KIF11MAPTKDM4EMEN1ALDH1A1
SCHEMBL3777574 0.79 PTGES2 (1.00) PTGES2CA2CA1CA9MAPT
SCHEMBL30194891 0.79 PTGES2 (0.54) PTGES2CA2CA1CA12CA9
SCHEMBL25042639 0.75 SMN1; SMN2 (0.51) KIF11MAPTKDM4EMEN1ALDH1A1
SCHEMBL20766416 0.75 CA2 (0.71) CA2CA1CA12CA9CA7
SCHEMBL30482561 0.75 SMN1; SMN2 (0.51) KIF11MAPTKDM4EMEN1ALDH1A1
SCHEMBL15875869 0.75 MAPT (0.68) MAPTKDM4EMEN1ALDH1A1GAA
SCHEMBL29824523 0.75 MAPT (0.68) MAPTKDM4EMEN1ALDH1A1GAA
SCHEMBL3774801 0.74 PTGES2 (1.00) PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3691623-A1 BENZOSULFONYL COMPOUNDS Vivace Therapeutics, Inc. (US) 2020-08-12 — — EP disclosed
WO-2019040380-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. (US) 2019-02-28 — — WO disclosed
Send feedback